research LB792 Minoxidil and Dutasteride Drug Tattooing for Male Androgenetic Alopecia
The technique effectively promotes hair growth in young men with androgenetic alopecia.
Search
for
Sort by
Research
390-420 / 1000+ results
research Two Cases of Paradoxical Nonscarring Alopecia After Mesotherapy with Dutasteride
Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.
research Dutasteride/Finasteride: A Retrospective Study on Macular Abnormalities in Male Patients Treated for Benign Prostatic Hypertrophy or Alopecia
Finasteride and dutasteride may cause macular abnormalities.
research Novel Mechanism of Action of Dutasteride for Inducing Hair Growth in Patients with Female-Pattern Hair Loss
Dutasteride helps increase hair density in patients with female-pattern hair loss by activating a new growth mechanism.
research A 25-Year-Old Man with Androgenetic Alopecia Developed Symptoms of Post-Finasteride Syndrome After Treatment with Finasteride and Dutasteride
Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.
research Dutasteride Micro-Injections in Androgenetic Alopecia
Small injections of dutasteride improved hair thickness in men with hair loss without major side effects.
research Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident HCV-Related Hepatocellular Carcinoma in Men
Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.
research Dual Effects of 5α-Reductase Inhibitor Dutasteride on Androgenetic Alopecia and Acne Vulgaris
Dutasteride improved both hair loss and acne in two young men.
research Change in Hair Growth-Related Gene Expression Profile in Human Isolated Hair Follicles Induced by 5-Alpha Reductase Inhibitors, Dutasteride and Finasteride, in the Presence of Testosterone
Dutasteride and finasteride can change hair growth genes, helping treat hair loss.
research Adverse Events with Finasteride or Dutasteride: FAERS
Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.
research Androgenic Alopecia and Dutasteride in Hair Mesotherapy: A Short Review
Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.
research Topical Dutasteride with Microneedling in Treatment of Male Androgenetic Alopecia
Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.
research Duration of Finasteride and Dutasteride Treatment Linked to Long-Term Erectile Dysfunction
Long use of finasteride and dutasteride can cause long-term erection problems.
research No Increased Risk of Cardiovascular Events with Dutasteride vs Finasteride
Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.
research Dutasteride, Finasteride: No Increased Risk of Erectile Dysfunction
Dutasteride and finasteride don't raise erectile dysfunction risk.
research Review: Dutasteride, Fesoterodine, and Finasteride Are Beneficial for Lower Urinary Tract Symptoms in Older Patients
Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.
research Finasteride And Dutasteride May Reduce Melanoma Risk
Finasteride and dutasteride might lower melanoma risk.
research Retrospective Pharmacotherapeutic Evaluation of Dutasteride Not Approved by US FDA for Androgenetic Alopecia in Korea
Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.
research Luncheon Symposium: Update on the Efficacy and Safety of Dutasteride in the Management of Androgenetic Alopecia
Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
research Faculty Opinions Recommendation of a Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia
Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.
research Faculty Opinions Recommendation of Dutasteride Improves Male Pattern Hair Loss in a Randomized Study in Identical Twins
Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.
research Dutasteride/Finasteride
research Dutasteride for Androgenetic Alopecia—Words of Caution
research Microneedling Plus Topical Dutasteride Solution for Androgenetic Alopecia: A Randomized Placebo-Controlled Study
Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.
research Dutasteride for Men with Androgenic Alopecia Unresponsive to Finasteride
research Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
research Finasteride Versus Dutasteride: A Real-World Economic Evaluation
research Evaluation of Dutasteride-Loaded Liposomes and Transfersomes for Follicular-Targeting for Androgenic Alopecia Topical Treatment
The study explores the use of dutasteride-loaded liposomes and transfersomes for treating androgenic alopecia, focusing on enhancing drug delivery to hair follicles. Transfersomes, due to their flexible structure, demonstrated superior follicular targeting (Tf = 0.32) compared to stiffer liposomes (Tf = 0.15) in in vitro tests on porcine skin. This suggests that transfersomes offer better initial control over drug release, making them a promising option for topical treatment. However, over 24 hours, drug distribution equilibrated across skin layers, indicating a need for further optimization to maintain targeting efficacy. The study underscores the potential of transfersomes for improved follicular targeting in alopecia treatment, though additional safety studies are required.
research Study of Dutasteride Recovery in Organic Solvents Versus Dutasteride Dissolved in Human Blood Plasma
The document's conclusion cannot be provided because the document is not available or cannot be parsed.